GlassScriptPhysician profile
Michael A Garvin
NPI 1013957166
$939.01
in general payments reported to CMS, 2019-2025
10 companies · $30.30 in 2025
The $30.30 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.21 · 2020: $12.81 · 2021: $363 · 2022: $175 · 2023: $20.72 · 2024: $242 · 2025: $30.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $347.71 | 2019-2024 | Physio-Stim |
| Horizon Therapeutics Plc | $143.09 | 2019-2021 | |
| Trice Medical, INC. | $109.83 | 2024 | |
| Paratek Pharmaceuticals, INC. | $107.42 | 2022-2024 | Nuzyra |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Kerecis Limited | $41.38 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $36.04 | 2022-2023 | Regranex, Collagenase Santyl |
| Organogenesis INC. | $26.17 | 2019 | |
| Djo, LLC | $23.00 | 2025 | Cmf |
| Mimedx Group, INC. | $14.54 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Garvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.